GeneDx Holdings Corp
NASDAQ:WGS

Watchlist Manager
GeneDx Holdings Corp Logo
GeneDx Holdings Corp
NASDAQ:WGS
Watchlist
Price: 158.96 USD -1.85% Market Closed
Market Cap: 4.6B USD

During the last 3 months GeneDx Holdings Corp insiders have not bought any shares, and sold 2.8m USD worth of shares. The stock price has increased by 23% over this period (open performance analysis).

The last transaction was made on Nov 24, 2025 by Ruch Joshua , who sold 31.8k USD worth of WGS shares.

Last Transactions:
Ruch Joshua
$-31.8k
Feeley Kevin
$-53k
Stueland Katherine
$-294.1k
Feeley Kevin
$-36.2k
Stueland Katherine
$-63.7k
Stueland Katherine
$-1.3m
Feeley Kevin
$-452.9k
Feeley Kevin
$-162.1k
Stueland Katherine
$-466k
Feeley Kevin
$-47.6k
Ryan Jason
$-1.1m
Casdin Partners Gp, Llc
$-60.5m
Feeley Kevin
$-40.9k
Stueland Katherine
$-226.8k
Stueland Katherine
$-299.5k
Feeley Kevin
$-490.9k
Feeley Kevin
$-90.7k
Stueland Katherine
$-628.2k
Feeley Kevin
$-241.5k
Stueland Katherine
$-680.2k
Feeley Kevin
$-91.8k
Stueland Katherine
$-264k
Feeley Kevin
$-26.4k
Meister Keith A.
$+1.5m
Meister Keith A.
$+4.4m
Feeley Kevin
$-43.9k
Stueland Katherine
$-243.6k
Stueland Katherine
$-164.3k
Feeley Kevin
$-53.3k
Feeley Kevin
$-53.3k
Feeley Kevin
$-805.2k
Stueland Katherine
$-1m
View All Transactions

During the last 3 months GeneDx Holdings Corp insiders have not bought any shares, and sold 2.8m USD worth of shares. The stock price has increased by 23% over this period (open performance analysis).

The last transaction was made on Nov 24, 2025 by Ruch Joshua , who sold 31.8k USD worth of WGS shares.

Sold
0-3
months
2.8m USD
3
3-6
months
64.7m USD
4
6-9
months
3.3m USD
2
9-12
months
6.3m USD
2
Bought
0-3
months
0
0 USD
3-6
months
0
0 USD
6-9
months
1
5.9m USD
9-12
months
0
0 USD

GeneDx Holdings Corp
Insider Trading Chart

GeneDx Holdings Corp
Insiders Performance

1 Week Later 1 Month Later 3 Months Later 6 Months Later 1 Year Later
Average Return
Median Return
Win Rate

GeneDx Holdings Corp
Last Insider Transactions

Global
Insiders Monitor

GeneDx Holdings Corp
Glance View

GeneDx Holdings Corp. holds a prominent spot in the realm of genetic testing and diagnostics, intertwining advanced technology with healthcare to create a substantial impact in personalized medicine. Originally founded with the mission to provide accessible genetic testing services, the company has evolved into a pivotal player in identifying rare genetic disorders through its specialized sequencing techniques. By leveraging next-generation sequencing (NGS), GeneDx can efficiently decode vast arrays of genetic information, enabling healthcare providers to diagnose and manage hereditary conditions more accurately. Their comprehensive test offerings cover everything from whole exome sequencing to disease-specific panels, catering to the needs of patients and clinicians alike. This tailored approach not only drives innovation but also establishes a firm foundation in genetic diagnostics, addressing some of the most pressing needs in modern medicine. In terms of revenue generation, GeneDx’s business model thrives on its collaborations with healthcare institutions, insurers, and research organizations. The company's ability to reduce the time and cost involved in traditional diagnostics creates a clear value proposition, encouraging widespread adoption of its services. Insurance reimbursements play a crucial role, as more healthcare policies expand to include genetic testing due to its significant potential for early disease detection and management. Moreover, strategic partnerships and continuous investments in research and development allow GeneDx to stay at the forefront of genomic insights, further strengthening its market position. By staying ahead of industry trends and focusing on expanding access to genetic information, GeneDx establishes itself not only as a leader in diagnostics but also as an integral force in the broader healthcare ecosystem, ensuring sustained growth and relevance.

WGS Intrinsic Value
49.47 USD
Overvaluation 69%
Intrinsic Value
Price

What is Insider Trading?

Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.

While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.

Why is Insider Trading Important?

It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.

However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.

Peter Lynch

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

Back to Top